After suffering its worst downturn in the past three decades, the hospital supplies industry will see improved demand in the next 12-18 months, the CEO of Becton Dickinson told CNBC. The past year or ...

Becton Dickinson's fiscal second-quarter earnings fell on higher costs, and the maker of catheters and other devices warned that tariffs would likely take a toll on profits this year even as it raised ...

The Johnson & Johnson spinoff that makes Tylenol and Benadryl, said Chief Executive Thibaut Mongon has departed and that the company is considering simplifying its portfolio amid a recent sales slump.

First Eagle Investments, an investment management company, released its “First Eagle Global Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. Class A shares of ...

Becton, Dickinson and Company's divestment of Biosciences & Diagnostics is accretive, unlocking value at a strong multiple and improving strategic focus. The deal with Waters reduces leverage, funds ...

Three months earlier than an expected update on a deal, Becton, Dickinson and Co. reported its biosciences and diagnostic solutions business will combine with Waters Corp. in a transaction valued at ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and ChemoGLO™, a specialist in ...

Becton Dickinson, and Company (NYSE:BDX) lowered its fiscal year 2025 guidance and provided an estimated tariff impact on Thursday. The medical device company reported adjusted earnings per share of ...

The firm has acquired Becton Dickinson's long-standing facility, safeguarding hundreds of skilled jobs and keeping advanced ...